Metabolon Announces Changes to Executive Leadership Team
26 janv. 2017 09h45 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 26, 2017 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced changes today to its executive team. David S. Memel, MD, MS, MBA, has...
Metabolon to Work With InnVentis to Study Chronic Inflammatory Diseases
05 janv. 2017 10h05 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced today that it has entered into an agreement with InnVentis Ltd. to apply...
Metabolon Raises Additional $15 Million in Funding From Essex Woodlands
05 déc. 2016 10h52 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced today that it has raised an additional $15 million in funding from...
Metabolon Launches Meta IMD™ Test to Speed Diagnosis of Inherited Metabolic Disorders
28 sept. 2016 10h05 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 28, 2016 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced today that Meta IMD™ is now available to physicians as a CLIA...
SNS FiRe Conference Names Metabolon Inc. a 2016 FiReStarter Company
01 sept. 2016 10h00 HE
|
Strategic News Service
SEATTLE, WA--(Marketwired - September 01, 2016) - Strategic News Service (SNS) has selected Metabolon Inc., the global leader in metabolomics, as a 2016 FiReStarter company to be featured at the 14th...
Metabolon Closes $15 Million Financing to Support Precision Medicine Growth Opportunities
11 août 2016 10h10 HE
|
Metabolon, Inc.
Financing Adds Essex Woodlands as New Investor Scott Barry to Join Metabolon’s Board of Directors RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global...
Metabolon to Develop accuGFR™ Kidney Function Test With Johns Hopkins and Tufts Medical Center
02 juin 2016 16h00 HE
|
Metabolon, Inc.
More accurate kidney function test needed for chronic kidney disease“Silent killer” can go undetected without symptoms until patient has lost 90 percent of kidney function RESEARCH TRIANGLE PARK,...
Metabolon Identifies Biomarkers with Superior Diagnostic Performance Over Creatinine for Chronic Kidney Disease
28 avr. 2016 15h50 HE
|
Metabolon, Inc.
Data presented at National Kidney Foundation 2016 Spring Clinical MeetingsMetabolites form basis of accuGFR™ test in development RESEARCH TRIANGLE PARK, N.C., April 28, 2016 (GLOBE NEWSWIRE) --...
Zivo Bioscience, Inc. Issues CEO Report for Q4 2015 and Q1 2016
18 avr. 2016 14h06 HE
|
Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., April 18, 2016 (GLOBE NEWSWIRE) -- In the nine months since the last shareholder meeting in late June of 2015, Zivo Bioscience (OTCQB:ZIVO) has continued to focus almost...
Metabolon and SYNLAB Group Form Commercialization Collaboration for Quantose™ IR Diagnostic
29 mars 2016 09h59 HE
|
Metabolon, Inc.
SYNLAB Group to market Quantose IR, a laboratory-developed test used to identify insulin resistanceInitial launch in SpainAdditional markets to follow in 2016 RESEARCH TRIANGLE PARK, N.C., March 29,...